MedPath

HANZEMA

HANZEMA

Approved
DIN Number

02477432

Drug Class

Human

Market Date

Jun 9, 2021

Company
HC

DR. REDDY'S LABORATORIES, INC.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02477432
AIG Number0137581002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
D11AH04 ALITRETINOIN
Product Specifications
Dosage FormCapsule
Route of AdministrationOral
AHFS Classification84:92.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

ALITRETINOINActive
Strength: 10 MG
Monograph: ALITRETINOIN

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.